News Column

New Personalized Medicine Findings from Stanford University Discussed (Translating personalized medicine using new genetic technologies in clinical...

July 18, 2014



New Personalized Medicine Findings from Stanford University Discussed (Translating personalized medicine using new genetic technologies in clinical practice: the ethical issues)

By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on Personalized Medicine. According to news reporting originating in Stanford, California, by NewsRx journalists, research stated, "The integration of new genetic technologies into clinical practice holds great promise for the personalization of medical care, particularly the use of large-scale DNA sequencing for genome-wide genetic testing. However, these technologies also yield unprecedented amounts of information whose clinical implications are not fully understood, and we are still developing technical standards for measuring sequence accuracy."

The news reporters obtained a quote from the research from Stanford University, "These technical and clinical challenges raise ethical issues that are similar to but qualitatively different from those that we are accustomed to dealing with for traditional medical genetics. The sheer amount of information afforded by genome sequencing requires rethinking of how to implement core ethical principles including, but not limited to: informed consent, privacy and data ownership and sharing, technology regulation, issues of access, particularly as new technology is integrated into clinical practice, and issues of potential stigma and impact on perceptions of disability."

According to the news reporters, the research concluded: "In this article, we will review the issues of informed consent, privacy, data ownership and technology regulation as they relate to the emerging field of personalized medicine and genomics."

For more information on this research see: Translating personalized medicine using new genetic technologies in clinical practice: the ethical issues. Personalized Medicine, 2014;11(2):211-222. Personalized Medicine can be contacted at: Future Medicine Ltd, Unitec House, 3RD Floor, 2 Albert Place, Finchley Central, London, N3 1QB, England (see also Personalized Medicine).

Our news correspondents report that additional information may be obtained by contacting K.E. Ormond, Stanford University, Dept. of Pediat, Stanford, CA 94305, United States.

Keywords for this news article include: Stanford, Genetics, California, Technology, United States, Personalized Medicine, North and Central America

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Health & Medicine Week


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters